Founder & CEO of GlucoScreen
Tele-healthcare is evolving, and our remote diagnostics need to catch up. I founded GlucoScreen, a low-cost smartphone-based test strip platform, to fill this emerging gap. As rates of chronic disease are growing, preventative care workflows are increasingly strained. Beginning with prediabetes screening, I’m building a line of accurate Rapid Diagnostic Test (RDT) strips that are immediately compatible with any smartphone. Validated in a proof-of-concept study in a lab and medical clinic setting, it proved to be as accurate as FDA-cleared purpose-built glucometers. The smartphone, already available in the pockets of billions of people worldwide, enables a consistent, familiar interface that guides users to accurately conduct tests, and proffers the results in a readable, actionable form.
As a former biomedical engineer and Program Manager at Microsoft, recently graduated with a PhD in computer science from the University of Washington and now a UW CoMotion Postdoctoral Entrepreneurship Fellow, I bring my skills and passion built from personal experience with the healthcare system to address this problem. I am bringing together an intuitive software experience with scaled manufacturing of novel test strips for biomarkers of many chronic diseases into the home directly with a smartphone.
This has the potential to simultaneously reduce the burden on primary care while empowering people with immediate access to their health information. At GlucoScreen, we are committed to empowering people to take control of their health, putting them in collaboration with their doctors and available treatment programs that help to reduce their risk of chronic disease and live up to their full potential.